Rising investments in the development of advanced microRNA techniques and tools contribute to the global market growth

The global microRNA (miRNA) market size is expected to reach USD 458.0 Million by 2028 at a CAGR of 11.6%, according to a new report by Reports and Data. Significant revenue growth is mainly attributed to increasing research development programs on genomics and RNA biology, rise in adoption of high-throughput miRNA analysis techniques, and emergence of next-generation miRNA sequencing techniques. Rising prevalence of chronic disorders such as cancer, increasing infectious disease outbreaks such as the ongoing COVID-19 pandemic, and growing applications of miRNA in the pharmaceutical and biotechnology sectors are other key factors responsible for market growth. Furthermore, major advancements in gene sequencing technologies and rise in government investments in life sciences RD activities bolster the global microRNA (miRNA) market growth.

A microRNA (miRNA) is a small, single-stranded RNA molecule present in animals, plants, and different viruses. Post-transcriptional regulation of gene expression and RNA silencing are two of the key functional areas of miRNAs. miRNAs complement messenger RNA (mRNA) in down-regulating the gene expression and also regulate several vital cellular functions such as cell differentiation, proliferation, and apoptosis. Besides identifying different cell types, they play an indispensable role in cell physiology and development and various pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. miRNAs are present in various mammalian cell types in large numbers. MicroRNA sequencing is a form of RNA sequencing that involves next-generation DNA sequencing technology and is performed by researchers to study miRNA isoforms, tissue-specific expression patterns, and disease associations.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1418

The report puts an emphasis on the information regarding the key players with a special focus on their company profile, business overview, recent advancements, product catalog, and strategic business plans. It provides a comprehensive overview of the strategic alliances in the market under taken by the key players such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches, brand promotions, and corporate deals, among others.

Key companies operating in the market and profiled in the report include:

Agilent Technologies, Exigon, Merck KGA, Illumina, Inc., NanoString Technologies, Inc., and Thermo Fischer Scientific 

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1418

The MicroRNA (miRNA) market takes into account major geographical locations such as North America, Europe, Asia Pacific, Latin America, and Middle East Africa to offer key insights into market growth, market size, market share, revenue growth, current and emerging trends, supply and demand ratio, import/export, consumer demand and behavior, and presence of key players in each region. The report offers an in-depth country wise analysis to impart better understanding of the market and its growth prospects.

Segments Covered in the report

Product Type Outlook (Revenue, USD Million; 2020-2028)

• Instruments
• Kits, Reagents, and Consumables
• Isolation Purification
• Quantification Detection
• Functional Analysis
• Others

Research Tools and Services Outlook (Revenue, USD Million; 2020-2028)

• Tools
• RT-PCR
• Biomarkers
• Next Gen Sequencing (NGS)
• Microarray Analysis Tools
• Functional Analysis Tools
• Extraction Tools
• Others
• Services
• miRNA cDNA Synthesis
• Quantification Services
• Microarray Services
• Sequencing Services
• Functional Studies Services
• Others

Application Outlook (Revenue, USD Million; 2020-2028)

• Cancer
• Infectious Diseases
• Immunological Disorder
• Cardiovascular Disease
• Neurological Disease
• Others

End-use Outlook (Revenue, USD Million; 2020-2028)

• Biopharmaceutical Companies
• Academic Research Institutes
• Contract Research Organizations (CROs)
• Diagnostic Centers

Key Regions Analyzed in the Report include:

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• U.K.
• Italy
• France
• BENELUX
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Rest of LATAM
• Middle East Africa
• Saudi Arabia
• U.A.E.
• South Africa
• Rest of MEA

To know more about the report @ https://www.reportsanddata.com/report-detail/microrna-mirna-market

Furthermore, it consists information about individual segment of the MicroRNA (miRNA) market based on the types and application. The report also offers insights about the key segments expected to register significant revenue growth over the forecast period and primary trends influencing their growth. It also offers CAGR and market share values for each segment to provide clear understanding of demand and trend in the global market.

Some Key Highlights in the Report:

• Based on product type, the kits, reagents, and consumables segment emerged as the most dominant segment in 2020, with the highest revenue share of over 60%. Growth of this segment can be attributed to extensive use of detection kits, consumables, qPCR primers, and transfection reagents miRNA profiling and analysis due to their non-durable nature.
• The RT-PCR research tools segment was the most dominant in 2020 and accounted for a revenue share of around 33% in the global microRNA (miRNA) market. High reliability and sequence specificity of this technique for detection of miRNA expression, increasing applications of RT-PCR in miRNA profiling, quantitation, validation, and analysis, and rapidly increasing volumes of RT-PCR tests for COVID-19 are the key factors driving the growth of this segment.
• North America accounted for the highest revenue share of around 45% in the global microRNA (miRNA) market in 2020. Market growth in this region is accelerated by increasing research development activities in the fields of genomics, proteomics, and oncology, introduction of advanced miRNA biomarkers, increasing RD investments in the biotechnology and biopharmaceutical industries, and the state-of-the-art healthcare infrastructure in North America.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1418

Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.

Browse More Reports:

Urinary Stone Treatment Device Market @ https://www.reportsanddata.com/report-detail/urinary-stone-treatment-devices-market

Orthopedics Instruments Market @ https://www.reportsanddata.com/report-detail/orthopedics-instrument-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:                                        

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com